AUG 10, 2026 · JOURNAL ARTICLE
Injectable Optoelectronic Probe With In Situ Photoactivation and ROS Monitoring for Oxygen‐Dependent Metronomic Photodynamic Cancer Therapy
Small
First-in-vivo demonstration of a novel injectable optoelectronic device with integrated oxygen monitoring for metronomic PDT; promising preclinical result in mouse tumor model but no human data, no comparator arm for the device itself, and surrogate efficacy endpoint.
Reported
p-value for efficacy comparison0.0047
Metronomic PDT frequency0.1 Hz
Treatment duration1.5 h